Strides Pharma Scien - Quarterly Results
10th May 2019

The Revenue for the quarter ended  March 2019 of Rs. 4345.60 millions grew by 11.71 % from Rs. 3890.20 millions.Good  Net Profit growth of 44.47% reported above the corresponding previous quarter figure of Rs. 684.00 millions to Rs. 988.20 millioins.Operating Profit reported a sharp decline to 1342.30 millions from 1542.90 millions in the corresponding previous quarter.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201903 201803 % Var 201903 201803 % Var 201903 201803 % Var
Sales 4345.60 3890.20 11.71 15374.40 14696.10 4.62 15374.40 14696.10 4.62
Other Income 564.10 494.60 14.05 1146.10 1562.00 -26.63 1146.10 1562.00 -26.63
PBIDT 1342.30 1542.90 -13.00 2536.40 3533.00 -28.21 2536.40 3533.00 -28.21
Interest 163.10 114.70 42.20 540.90 819.70 -34.01 540.90 819.70 -34.01
PBDT 1164.10 1113.90 4.51 1960.30 2419.50 -18.98 1960.30 2419.50 -18.98
Depreciation 215.10 206.90 3.96 830.00 778.10 6.67 830.00 778.10 6.67
PBT 949.00 907.00 4.63 1130.30 1641.40 -31.14 1130.30 1641.40 -31.14
TAX -39.20 223.00 -117.58 -13.80 76.80 -117.97 -13.80 76.80 -117.97
Deferred Tax -198.40 56.60 -450.53 -260.10 -296.40 -12.25 -260.10 -296.40 -12.25
PAT 988.20 684.00 44.47 1144.10 1564.60 -26.88 1144.10 1564.60 -26.88
Equity 895.50 893.69 0.20 895.50 893.69 0.20 895.50 893.69 0.20
PBIDTM(%) 30.89 39.66 -22.12 16.50 24.04 -31.38 16.50 24.04 -31.38